The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

Immunologists from the Institute have been the first to uncover a role for a family of RNA binding proteins in the function ...

Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into ...

Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

The siRNA technology has has the potential to enable sustained and precise messenger RNA silencing, regulating the expression ...

President Donald Trump's tax cut and spending bill faces a critical stress test on Wednesday as Republicans in the U.S. House ...

AbbVie is paying ADARx Pharmaceuticals $335 million upfront to secure options on next-gen small interfering RNA (siRNA) ...